Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections, The Lancet Infectious Diseases, vol.6, issue.9, pp.589-601, 2006. ,
DOI : 10.1016/S1473-3099(06)70580-1
Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus, The Lancet Infectious Diseases, vol.15, issue.2, pp.225-259, 2015. ,
DOI : 10.1016/S1473-3099(14)70850-3
Pharmacokinetics of four different brands of colistimethate and formed colistin in rats, Journal of Antimicrobial Chemotherapy, vol.68, issue.10, pp.2311-2318, 2013. ,
DOI : 10.1093/jac/dkt207
Gastric stability and oral bioavailability of colistin sulfate in pigs challenged or not with Escherichia coli O149: F4 (K88), Research in Veterinary Science, vol.102, pp.173-81, 2015. ,
DOI : 10.1016/j.rvsc.2015.08.005
Effects of Antibiotic Physicochemical Properties on Their Release Kinetics from Biodegradable Polymer Microparticles, Pharmaceutical Research, vol.145, issue.Suppl 2, pp.3379-89, 2014. ,
DOI : 10.1007/s11095-014-1427-y
Pharmacology of polymyxins: new insights into an ???old??? class of antibiotics, Future Microbiology, vol.8, issue.6, pp.711-735, 2013. ,
DOI : 10.2217/fmb.13.39
Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria, International Journal of Antimicrobial Agents, vol.25, issue.1, pp.11-25, 2005. ,
DOI : 10.1016/j.ijantimicag.2004.10.001
Pharmacokinetics and pharmacodynamics of ???old??? polymyxins: what is new?, Diagnostic Microbiology and Infectious Disease, vol.74, issue.3, pp.213-236, 2012. ,
DOI : 10.1016/j.diagmicrobio.2012.07.010
???Old??? antibiotics for emerging multidrug-resistant bacteria, Current Opinion in Infectious Diseases, vol.25, issue.6, pp.626-659, 2012. ,
DOI : 10.1097/QCO.0b013e328358afe5
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4242550
Population Pharmacokinetics of Colistin Methanesulfonate in Rats: Achieving Sustained Lung Concentrations of Colistin for Targeting Respiratory Infections, Antimicrobial Agents and Chemotherapy, vol.57, issue.10, pp.5087-95, 2013. ,
DOI : 10.1128/AAC.01127-13
https://www.drugbank.ca/drugs/ DB01111, 2016. ,
https://www.drugbank.ca/drugs/DB00803, 2016. ,
Self-Assembly Behavior of Colistin and Its Prodrug Colistin Methanesulfonate: Implications for Solution Stability and Solubilization, The Journal of Physical Chemistry B, vol.114, issue.14, pp.4836-4876, 2010. ,
DOI : 10.1021/jp100458x
Stability of Colistin Methanesulfonate in Pharmaceutical Products and Solutions for Administration to Patients, Antimicrobial Agents and Chemotherapy, vol.52, issue.9, pp.3047-51, 2008. ,
DOI : 10.1128/AAC.00103-08
Assay of colistin and colistin methanesulfonate in plasma and urine by liquid chromatography tandem mass spectrometry (LC?MS/ MS), Antimicrob Agents Chemother, vol.22, issue.54, pp.1941-1949, 2010. ,
Simple Method for Assaying Colistin Methanesulfonate in Plasma and Urine Using High-Performance Liquid Chromatography, Antimicrobial Agents and Chemotherapy, vol.46, issue.10, pp.3304-3311, 2002. ,
DOI : 10.1128/AAC.46.10.3304-3307.2002
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC128774
Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate, Journal of Antimicrobial Chemotherapy, vol.53, issue.5, pp.837-877, 2004. ,
DOI : 10.1093/jac/dkh167
Development and validation of a high-performance liquid chromatographyfluorescence detection method for the accurate quantification of colistin in human plasma, J Chromatogr B Anal Technol Biomed Life Sci, vol.1, issue.980, pp.48-54, 2015. ,
A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversed-phase high-performance liquid chromatography, Journal of Chromatography B: Biomedical Sciences and Applications, vol.761, issue.2, pp.167-75, 2001. ,
DOI : 10.1016/S0378-4347(01)00326-7
Development, validation and application of an ultra high performance liquid chromatographic-tandem mass spectrometric method for the simultaneous detection and quantification of five different classes of veterinary antibiotics in swine manure, Journal of Chromatography A, vol.1429, pp.248-57, 1429. ,
DOI : 10.1016/j.chroma.2015.12.046
Quantitative analysis of colistin A and colistin B in plasma and culture medium using a simple precipitation step followed by LC/MS/MS, Journal of Pharmaceutical and Biomedical Analysis, vol.49, issue.3, pp.760-767, 2009. ,
DOI : 10.1016/j.jpba.2008.12.016
Aerosol Therapy with Colistin Methanesulfonate: a Biopharmaceutical Issue Illustrated in Rats, Antimicrobial Agents and Chemotherapy, vol.54, issue.9, pp.3702-3709, 2010. ,
DOI : 10.1128/AAC.00411-10
Colistin and Polymyxin B: Peas in a Pod, or Chalk and Cheese?, Clinical Infectious Diseases, vol.59, issue.1, pp.88-94, 2014. ,
DOI : 10.1093/cid/ciu213
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4305129
Colistin, mechanisms and prevalence of resistance, Current Medical Research and Opinion, vol.31, issue.4, pp.707-728, 2015. ,
DOI : 10.1185/03007995.2015.1018989
Leakage of periplasmic proteins from Escherichia coli mediated by polymyxin B nonapeptide., Antimicrobial Agents and Chemotherapy, vol.29, issue.5, pp.781-789, 1986. ,
DOI : 10.1128/AAC.29.5.781
Locus of Divalent Cation Inhibition of the Bactericidal Action of Polymyxin B, Antimicrobial Agents and Chemotherapy, vol.2, issue.5, pp.331-336, 1972. ,
DOI : 10.1128/AAC.2.5.331
Interaction of divalent cations and polymyxin B with lipopolysaccharide, Biochemistry, vol.18, issue.20, pp.4425-4455, 1979. ,
DOI : 10.1021/bi00587a024
Activity of Colistin against Pseudomonas aeruginosa: Inhibition by Calcium, Journal of Infectious Diseases, vol.124, issue.6, pp.610-612, 1971. ,
DOI : 10.1093/infdis/124.6.610
Gram-Negative Outer and Inner Membrane Models:?? Insertion of Cyclic Cationic Lipopeptides, The Journal of Physical Chemistry B, vol.111, issue.3, pp.551-63, 2007. ,
DOI : 10.1021/jp064757+
Binding of polycationic antibiotics and polyamines to lipopolysaccharides of Pseudomonas aeruginosa, J Bacteriol, vol.164, issue.3, pp.1256-61, 1985. ,
Antiendotoxin activity of cationic peptide antimicrobial agents, Infect Immun, vol.64, issue.12, pp.4922-4929, 1996. ,
Colistin in multi-drug resistant Pseudomonas aeruginosa blood-stream infections, Journal of Infection, vol.69, issue.1, pp.1-12, 2014. ,
DOI : 10.1016/j.jinf.2014.03.001
Lactulose as an antiendotoxin in experimental colitis, British Journal of Surgery, vol.90, issue.4, pp.469-72, 1995. ,
DOI : 10.1002/bjs.1800820413
Effect of colistin on reduction of biliary flow induced by endotoxin ofE. coli, Digestive Diseases and Sciences, vol.69, issue.10, pp.875-884, 1982. ,
DOI : 10.1007/BF01316569
Electron microscopy of effect of polymyxin on Escherichia coli lipopolysaccharide, J Bacteriol, vol.100, issue.2, pp.1128-1137, 1969. ,
Polymyxin and Related Peptide Antibiotics, Annual Review of Biochemistry, vol.46, issue.1, pp.723-63, 1977. ,
DOI : 10.1146/annurev.bi.46.070177.003451
A secondary mode of action of polymyxins against Gram-negative bacteria involves the inhibition of NADH-quinone oxidoreductase activity, The Journal of Antibiotics, vol.251, issue.2, pp.147-51, 2014. ,
DOI : 10.1074/jbc.M411217200
Polymyxin B versus colistin: an update, Expert Review of Anti-infective Therapy, vol.13, issue.12, pp.1481-97, 2015. ,
DOI : 10.1586/14787210.2015.1093933
Colistin MIC Variability by Method for Contemporary Clinical Isolates of Multidrug-Resistant Gram-Negative Bacilli, Journal of Clinical Microbiology, vol.51, issue.6, pp.1678-84, 2013. ,
DOI : 10.1128/JCM.03385-12
Comparative Evaluation of the VITEK 2, Disk Diffusion, Etest, Broth Microdilution, and Agar Dilution Susceptibility Testing Methods for Colistin in Clinical Isolates, Including Heteroresistant Enterobacter cloacae and Acinetobacter baumannii Strains, Antimicrobial Agents and Chemotherapy, vol.51, issue.10, pp.3726-3756, 2007. ,
DOI : 10.1128/AAC.01406-06
Comparative Evaluation of Colistin Susceptibility Testing Methods among Carbapenem-Nonsusceptible Klebsiella pneumoniae and Acinetobacter baumannii Clinical Isolates, Antimicrobial Agents and Chemotherapy, vol.59, issue.8, pp.4625-4655, 2015. ,
DOI : 10.1128/AAC.00868-15
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505270
Polymyxins: a review of the current status including recent developments, Ann Acad Med Singap, vol.37, issue.10, pp.870-83, 2008. ,
Correlation between overexpression and amino acid substitution of the PmrAB locus and colistin resistance in Acinetobacter baumannii, International Journal of Antimicrobial Agents, vol.37, issue.6, pp.525-555, 2011. ,
DOI : 10.1016/j.ijantimicag.2011.02.008
The Salmonella PmrAB regulon: lipopolysaccharide modifications, antimicrobial peptide resistance and more, Trends in Microbiology, vol.16, issue.6, pp.284-90, 2008. ,
DOI : 10.1016/j.tim.2008.03.007
Differential Expression of Two-Component Systems, pmrAB and phoPQ, with Different Growth phases of Klebsiella pneumoniae in the Presence or Absence of Colistin, Current Microbiology, vol.54, issue.1, pp.37-41, 2014. ,
DOI : 10.1007/s00284-014-0549-0
Discovery of new biosynthetic pathways: the lipid A story, The Journal of Lipid Research, vol.50, issue.Supplement, pp.103-111, 2009. ,
DOI : 10.1194/jlr.R800060-JLR200
The Two-Component System CprRS Senses Cationic Peptides and Triggers Adaptive Resistance in Pseudomonas aeruginosa Independently of ParRS, Antimicrobial Agents and Chemotherapy, vol.56, issue.12, pp.6212-6234, 2012. ,
DOI : 10.1128/AAC.01530-12
Contribution of the PhoP-PhoQ and PmrA-PmrB Two-Component Regulatory Systems to Mg2+-Induced Gene Regulation in Pseudomonas aeruginosa, Journal of Bacteriology, vol.188, issue.11, pp.3995-4006, 2006. ,
DOI : 10.1128/JB.00053-06
Phosphoethanolamine Modification of Lipid A in Colistin-Resistant Variants of Acinetobacter baumannii Mediated by the pmrAB Two-Component Regulatory System, Antimicrobial Agents and Chemotherapy, vol.55, issue.7, pp.3370-3379, 2011. ,
DOI : 10.1128/AAC.00079-11
Genomic insights into the fate of colistin resistance and Acinetobacter baumannii during patient treatment, Genome Research, vol.23, issue.7, pp.1155-62, 2013. ,
DOI : 10.1101/gr.154328.112
Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study, The Lancet Infectious Diseases, vol.16, issue.2, pp.161-169, 2016. ,
DOI : 10.1016/S1473-3099(15)00424-7
Transferable resistance to colistin: a new but old threat: Table??1., Journal of Antimicrobial Chemotherapy, vol.71, issue.8, pp.2066-70, 2016. ,
DOI : 10.1093/jac/dkw274
Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production, Antimicrobial Agents and Chemotherapy, vol.54, issue.12, pp.4971-4978, 2010. ,
DOI : 10.1128/AAC.00834-10
Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumannii, Antimicrobial Agents and Chemotherapy, vol.50, issue.9, pp.2946-50, 2006. ,
DOI : 10.1128/AAC.00103-06
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1563544
Evolved resistance to colistin and its loss due to genetic reversion in Pseudomonas aeruginosa, Scientific Reports, vol.41, issue.1, p.25543, 2016. ,
DOI : 10.1128/AAC.01252-10
Persister cells, dormancy and infectious disease, Nature Reviews Microbiology, vol.71, issue.1, pp.48-56, 2007. ,
DOI : 10.1128/AAC.00684-06
Pharmacokinetics of Colistin and Colistimethate Sodium After a Single 80-mg Intravenous Dose of CMS in Young Healthy Volunteers, Clinical Pharmacology & Therapeutics, vol.72, issue.6, pp.875-884, 2011. ,
DOI : 10.1128/AAC.01367-09
Colistin pharmacokinetics: the fog is lifting, Clinical Microbiology and Infection, vol.18, issue.1, pp.30-39, 2012. ,
DOI : 10.1111/j.1469-0691.2011.03667.x
URL : http://doi.org/10.1111/j.1469-0691.2011.03667.x
Renal Disposition of Colistin in the Isolated Perfused Rat Kidney, Antimicrobial Agents and Chemotherapy, vol.53, issue.7, pp.2857-64, 2009. ,
DOI : 10.1128/AAC.00030-09
Human oligopeptide transporter 2 (PEPT2) mediates cellular uptake of polymyxins, Journal of Antimicrobial Chemotherapy, vol.71, issue.2, pp.403-415, 2016. ,
DOI : 10.1093/jac/dkv340
Megalin Contributes to Kidney Accumulation and Nephrotoxicity of Colistin, Antimicrobial Agents and Chemotherapy, vol.57, issue.12, pp.6319-6343, 2013. ,
DOI : 10.1128/AAC.00254-13
Pharmacokinetics and Pharmacokinetic???Pharmacodynamic Correlations of Therapeutic Peptides, Clinical Pharmacokinetics, vol.96, issue.1, pp.855-68, 2013. ,
DOI : 10.1007/s40262-013-0079-0
Structure???activity relationships for the binding of polymyxins with human ??-1-acid glycoprotein, Biochemical Pharmacology, vol.84, issue.3, pp.278-91, 2012. ,
DOI : 10.1016/j.bcp.2012.05.004
New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection, J Antimicrob Chemother, vol.70, issue.12, pp.3291-3298, 2015. ,
Use of High-Performance Liquid Chromatography To Study the Pharmacokinetics of Colistin Sulfate in Rats following Intravenous Administration, Antimicrobial Agents and Chemotherapy, vol.47, issue.5, pp.1766-70, 2003. ,
DOI : 10.1128/AAC.47.5.1766-1770.2003
Feasibility of microdialysis for determination of protein binding and target site pharmacokinetics of colistin in vivo, The Journal of Clinical Pharmacology, vol.57, issue.7, pp.431-438, 2015. ,
DOI : 10.1002/jcph.419
Pharmacologic and Toxicologic Studies with the Polymyxins. III. Considerations Regarding Clinical Use in Dogs, Chemotherapy, vol.19, issue.2, pp.98-108, 1973. ,
DOI : 10.1159/000221444
Application of a Loading Dose of Colistin Methanesulfonate in Critically Ill Patients: Population Pharmacokinetics, Protein Binding, and Prediction of Bacterial Kill, Antimicrobial Agents and Chemotherapy, vol.56, issue.8, pp.4241-4250, 2012. ,
DOI : 10.1128/AAC.06426-11
Drug binding to human alpha-1-acid glycoprotein in health and disease, Pharmacol Rev, vol.40, issue.1, pp.1-47, 1988. ,
Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients, Clinical Infectious Diseases, vol.47, issue.10, pp.1298-304, 2008. ,
DOI : 10.1086/592577
Mucin Binding Reduces Colistin Antimicrobial Activity, Antimicrobial Agents and Chemotherapy, vol.59, issue.10, pp.5925-5956, 2015. ,
DOI : 10.1128/AAC.00808-15
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4576126
Steady-State Pharmacokinetics and BAL Concentration of Colistin in Critically Ill Patients After IV Colistin Methanesulfonate Administration, Chest, vol.138, issue.6, pp.1333-1342, 2010. ,
DOI : 10.1378/chest.10-0463
Comparison of Intrapulmonary and Systemic Pharmacokinetics of Colistin Methanesulfonate (CMS) and Colistin after Aerosol Delivery and Intravenous Administration of CMS in Critically Ill Patients, Antimicrobial Agents and Chemotherapy, vol.58, issue.12, pp.7331-7340, 2014. ,
DOI : 10.1128/AAC.03510-14
Pulmonary and Systemic Pharmacokinetics of Inhaled and Intravenous Colistin Methanesulfonate in Cystic Fibrosis Patients: Targeting Advantage of Inhalational Administration, Antimicrobial Agents and Chemotherapy, vol.58, issue.5, pp.2570-2579, 2014. ,
DOI : 10.1128/AAC.01705-13
Transport mechanisms at the pulmonary mucosa: implications for drug delivery, Expert Opinion on Drug Delivery, vol.268, issue.3, pp.667-90, 2016. ,
DOI : 10.1111/cge.12392
Transport of Ipratropium, an Anti-Chronic Obstructive Pulmonary Disease Drug, Is Mediated by Organic Cation/Carnitine Transporters in Human Bronchial Epithelial Cells: Implications for Carrier-Mediated Pulmonary Absorption, Molecular Pharmaceutics, vol.7, issue.1, pp.187-95, 2010. ,
DOI : 10.1021/mp900206j
Aerosolized plus Intravenous Colistin versus Intravenous Colistin Alone for the Treatment of Ventilator???Associated Pneumonia: A Matched Case???Control Study, Clinical Infectious Diseases, vol.51, issue.11, pp.1238-1282, 2010. ,
DOI : 10.1086/657242
Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study, Clinical Microbiology and Infection, vol.16, issue.8, pp.1230-1236, 2010. ,
DOI : 10.1111/j.1469-0691.2009.03040.x
Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: A prospective study, Respiratory Medicine, vol.102, issue.3, pp.407-419, 2008. ,
DOI : 10.1016/j.rmed.2007.10.011
Effect of Aerosolized Colistin as Adjunctive Treatment on the Outcomes of Microbiologically Documented Ventilator-Associated Pneumonia Caused by Colistin-Only Susceptible Gram-Negative Bacteria, Chest, vol.144, issue.6, pp.1768-75, 2013. ,
DOI : 10.1378/chest.13-1018
Biopharmaceutical Characterization of Nebulized Antimicrobial Agents in Rats: 2. Colistin, Antimicrobial Agents and Chemotherapy, vol.58, issue.7, pp.3950-3956, 2014. ,
DOI : 10.1128/AAC.02819-14
Pharmacokinetics of inhaled colistin in patients with cystic fibrosis, Journal of Antimicrobial Chemotherapy, vol.57, issue.2, pp.306-317, 2006. ,
DOI : 10.1093/jac/dki461
Pharmacokinetics of inhaled colistimethate sodium (CMS) in mechanically ventilated critically ill patients, Intensive Care Medicine, vol.124, issue.4, pp.1779-86, 2012. ,
DOI : 10.1007/s00134-012-2628-7
Penetration of Colistin into Cerebrospinal Fluid, Antimicrobial Agents and Chemotherapy, vol.53, issue.11, pp.4907-4917, 2009. ,
DOI : 10.1128/AAC.00345-09
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2772309
Combined Intravenous and Intraventricular Administration of Colistin Methanesulfonate in Critically Ill Patients with Central Nervous System Infection, Antimicrobial Agents and Chemotherapy, vol.57, issue.4, pp.1938-1978, 2013. ,
DOI : 10.1128/AAC.01461-12
Serum and Cerebrospinal Fluid Levels of Colistin in Pediatric Patients, Antimicrobial Agents and Chemotherapy, vol.54, issue.9, pp.3985-3992, 2010. ,
DOI : 10.1128/AAC.01799-09
Species-Dependent Blood-Brain Barrier Disruption of Lipopolysaccharide: Amelioration by Colistin In Vitro and In Vivo, Antimicrobial Agents and Chemotherapy, vol.57, issue.9, pp.4336-4378, 2013. ,
DOI : 10.1128/AAC.00765-13
Pharmacokinetics of Colistin in Cerebrospinal Fluid after Intraventricular Administration of Colistin Methanesulfonate, Antimicrobial Agents and Chemotherapy, vol.56, issue.8, pp.4416-4437, 2012. ,
DOI : 10.1128/AAC.00231-12
Colistin Distribution in the Peritoneal Fluid of a Patient with Severe Peritonitis, Antimicrobial Agents and Chemotherapy, vol.56, issue.7, pp.4035-4041, 2012. ,
DOI : 10.1128/AAC.00478-12
Determination of a dosage regimen of colistin by pharmacokinetic/pharmacodynamic integration and modeling for treatment of G.I.T. disease in pigs, Research in Veterinary Science, vol.88, issue.2, pp.307-321, 2010. ,
DOI : 10.1016/j.rvsc.2009.09.001
Perioperative selective decontamination of the digestive tract and standard antibiotic prophylaxis versus standard antibiotic prophylaxis alone in elective colorectal cancer patients, Dan Med J, vol.61, issue.4, p.4695, 2014. ,
Decolonization of intestinal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, doubleblind , placebo-controlled trial, J Antimicrob Chemother, vol.68, issue.10, pp.2375-82, 2013. ,
Selective decontamination of the oral and digestive tract in surgical versus non-surgical patients in intensive care in a cluster-randomized trial, British Journal of Surgery, vol.11, issue.2, pp.232-239, 2012. ,
DOI : 10.1002/bjs.7703
Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: A prospective controlled trial, American Journal of Infection Control, vol.41, issue.12, pp.1167-72, 2013. ,
DOI : 10.1016/j.ajic.2013.04.018
Conclusions., Infection Control & Hospital Epidemiology, vol.46, issue.01, pp.14-23, 2012. ,
DOI : 10.1097/QCO.0b013e32833ae214
Selection of Colistin Resistance as a Consequence of Selective Decontamination of the Gastrointestinal Tract, Journal of Clinical Microbiology, vol.51, issue.1, pp.369-72, 2013. ,
DOI : 10.1128/JCM.02234-12
Emergence of Colistin Resistance in Enterobacteriaceae after the Introduction of Selective Digestive Tract Decontamination in an Intensive Care Unit, Antimicrobial Agents and Chemotherapy, vol.57, issue.7, pp.3224-3233, 2013. ,
DOI : 10.1128/AAC.02634-12
Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: a single-centre experience, International Journal of Antimicrobial Agents, vol.42, issue.6, pp.565-70, 2013. ,
DOI : 10.1016/j.ijantimicag.2013.08.008
Orally administered colistin leads to colistin-resistant intestinal flora and fails to prevent faecal colonisation with extended-spectrum ??-lactamase-producing enterobacteria in hospitalised newborns, International Journal of Antimicrobial Agents, vol.37, issue.1, pp.67-76, 2011. ,
DOI : 10.1016/j.ijantimicag.2010.09.010
URL : https://hal.archives-ouvertes.fr/hal-00651645
Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients, Antimicrobial Agents and Chemotherapy, vol.55, issue.7, pp.3284-94, 2011. ,
DOI : 10.1128/AAC.01733-10
New Colistin Population Pharmacokinetic Data in Critically Ill Patients Suggesting an Alternative Loading Dose Rationale, Antimicrobial Agents and Chemotherapy, vol.58, issue.12, pp.7324-7354, 2014. ,
DOI : 10.1128/AAC.03508-14
Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria, Antimicrobial Agents and Chemotherapy, vol.53, issue.8, pp.3430-3436, 2009. ,
DOI : 10.1128/AAC.01361-08
Dosing guidance for intravenous colistin in critically-ill patients, Clinical Infectious Diseases ,
DOI : 10.1093/cid/ciw839
Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients, Antimicrobial Agents and Chemotherapy, vol.59, issue.12, pp.7240-7248, 2015. ,
DOI : 10.1128/AAC.00554-15
Colistin loading dose: evaluation of the published pharmacokinetic and clinical data, International Journal of Antimicrobial Agents, vol.48, issue.5, pp.475-84, 2016. ,
DOI : 10.1016/j.ijantimicag.2016.08.009
Committee for Medicinal Products for Human Use (CHMP) Assessment report. Polymyxinbased products, 2014. ,
Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?, Clinical Infectious Diseases, vol.62, issue.5, pp.552-560, 2016. ,
DOI : 10.1093/cid/civ964
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741361
Population Pharmacokinetics of Colistin Methanesulfonate and Colistin in Critically Ill Patients with Acute Renal Failure Requiring Intermittent Hemodialysis, Antimicrobial Agents and Chemotherapy, vol.60, issue.3, pp.1788-93, 2016. ,
DOI : 10.1128/AAC.01868-15
Acute respiratory muscle weakness and apnea in a critically ill patient induced by colistin neurotoxicity: key potential role of hemoadsorption elimination during continuous venovenous hemofiltration, International Journal of Nephrology and Renovascular Disease, vol.6, pp.107-118, 2013. ,
DOI : 10.2147/IJNRD.S42791
Extracorporeal clearance of colistin methanesulphonate and formed colistin in end-stage renal disease patients receiving intermittent haemodialysis: implications for dosing, Journal of Antimicrobial Chemotherapy, vol.70, issue.6, pp.1804-1815, 2015. ,
DOI : 10.1093/jac/dkv031
Effective removal of colistin methanesulphonate and formed colistin during intermittent haemodialysis in a patient infected by polymyxin-only-susceptible Pseudomonas aeruginosa ,
Removal of colistin during intermittent haemodialysis in two critically ill patients, Journal of Antimicrobial Chemotherapy, vol.65, issue.8, pp.1836-1843, 2010. ,
DOI : 10.1093/jac/dkq185
Colistin pharmacokinetics in intensive care unit patients on continuous venovenous haemodiafiltration: an observational study, Journal of Antimicrobial Chemotherapy, vol.67, issue.10, pp.2459-62, 2012. ,
DOI : 10.1093/jac/dks257
Colistin Methanesulfonate and Colistin Pharmacokinetics in Critically Ill Patients Receiving Continuous Venovenous Hemodiafiltration, Antimicrobial Agents and Chemotherapy, vol.57, issue.1, pp.668-71, 2013. ,
DOI : 10.1128/AAC.00985-12
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3535942
Challenge for higher colistin dosage in critically ill patients receiving continuous venovenous haemodiafiltration, International Journal of Antimicrobial Agents, vol.48, issue.3, pp.337-378, 2016. ,
DOI : 10.1016/j.ijantimicag.2016.06.008
Colistin Use in Patients With Reduced Kidney Function, American Journal of Kidney Diseases, vol.68, issue.2, pp.296-306, 2016. ,
DOI : 10.1053/j.ajkd.2016.03.421
Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis, Journal of Antimicrobial Chemotherapy, vol.52, issue.6, pp.987-92, 2003. ,
DOI : 10.1093/jac/dkg468
Plasma pharmacokinetics and sputum concentrations of colistin after nebulization or intravenous administration of colistin methansulphonate (CMS) to ambulatories cystic fibrosis patients, 52nd international conference on antimicrobial agents and chemotherapy (ICAAC), pp.9-12, 2012. ,
The Treatment of Respiratory Pseudomonas Infection in Cystic Fibrosis, Drugs, vol.43, issue.6, pp.1053-64, 2000. ,
DOI : 10.2165/00003495-200060050-00006
Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15??years experience, Journal of Cystic Fibrosis, vol.7, issue.6, pp.523-553, 2008. ,
DOI : 10.1016/j.jcf.2008.06.009
Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study, Thorax, vol.68, issue.4, pp.344-50, 2013. ,
DOI : 10.1136/thoraxjnl-2012-202059
Population Pharmacokinetic Analysis of Colistin in Burn Patients, Antimicrobial Agents and Chemotherapy, vol.57, issue.5, pp.2141-2147, 2013. ,
DOI : 10.1128/AAC.00271-13
Safety and pharmacokinetic evaluation of intravenous colistin methanesulfonate sodium in Japanese healthy male subjects, Current Medical Research and Opinion, vol.27, issue.12, pp.2261-70, 2011. ,
DOI : 10.1185/03007995.2011.626557
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies, Critical Care, vol.10, issue.1, p.27, 2006. ,
DOI : 10.1186/cc3995
Colistin-associated Acute Kidney Injury in Severely Ill Patients: A Step Toward a Better Renal Care? A Prospective Cohort Study, Clinical Infectious Diseases, vol.61, issue.12, pp.611771-611778, 2015. ,
DOI : 10.1093/cid/civ717
Validation of a Model To Predict the Risk of Nephrotoxicity in Patients Receiving Colistin, Antimicrobial Agents and Chemotherapy, vol.58, issue.11, pp.6946-6954, 2014. ,
DOI : 10.1128/AAC.03776-14
Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study, BMC Infectious Diseases, vol.30, issue.5, p.380, 2013. ,
DOI : 10.1016/j.clinthera.2008.01.015
Colistin Dosing and Nephrotoxicity in a Large Community Teaching Hospital, Antimicrobial Agents and Chemotherapy, vol.54, issue.10, pp.4503-4508, 2010. ,
DOI : 10.1128/AAC.01707-09
The safety of polymyxin antibiotics, Expert Opinion on Drug Safety, vol.54, issue.11, pp.1687-701, 2015. ,
DOI : 10.1111/j.1469-0691.2006.01559.x
Preliminary Clinical Study of the Effect of Ascorbic Acid on Colistin-Associated Nephrotoxicity, Antimicrobial Agents and Chemotherapy, vol.59, issue.6, pp.3224-3256, 2015. ,
DOI : 10.1128/AAC.00280-15
Cellular Uptake and Localization of Polymyxins in Renal Tubular Cells Using Rationally Designed Fluorescent Probes, Antimicrobial Agents and Chemotherapy, vol.59, issue.12, pp.7489-96, 2015. ,
DOI : 10.1128/AAC.01216-15
Convulsions and apnoea in a patient infected with New Delhi metallo-??-lactamase-1 Escherichia coli treated with colistin, Journal of Infection, vol.63, issue.6, pp.468-70, 2011. ,
DOI : 10.1016/j.jinf.2011.07.008
Inhaled colistin for lower respiratory tract infections, Expert Opinion on Drug Delivery, vol.2010, issue.2, pp.333-375 ,
DOI : 10.1183/09031936.02.00230602
Colistin for lung infection: an update, Journal of Intensive Care, vol.3, issue.1, p.3, 2015. ,
DOI : 10.1093/cid/cir934
URL : http://doi.org/10.1186/s40560-015-0072-9
Intrathecal or intraventricular colistin: a review, Infez Med, vol.24, issue.1, pp.3-11, 2016. ,
Colistin: how should it be dosed for the critically ill? Semin Respir Crit Care Med, pp.126-161, 2015. ,
DOI : 10.1055/s-0034-1398390
Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonate, International Journal of Antimicrobial Agents, vol.48, issue.6, pp.725-732, 2016. ,
DOI : 10.1016/j.ijantimicag.2016.08.020
Pharmacokinetic/Pharmacodynamic Investigation of Colistin against Pseudomonas aeruginosa Using an In Vitro Model, Antimicrobial Agents and Chemotherapy, vol.54, issue.9, pp.3783-3792, 2010. ,
DOI : 10.1128/AAC.00903-09
Elucidation of the Pharmacokinetic/Pharmacodynamic Determinant of Colistin Activity against Pseudomonas aeruginosa in Murine Thigh and Lung Infection Models, Antimicrobial Agents and Chemotherapy, vol.54, issue.3, pp.1117-1141, 2010. ,
DOI : 10.1128/AAC.01114-09
A pharmacokinetic/pharmacodynamic model developed for the effect of colistin on Pseudomonas aeruginosa in vitro with evaluation of population pharmacokinetic variability on simulated bacterial killing, Journal of Antimicrobial Chemotherapy, vol.69, issue.5, pp.1350-61, 2014. ,
DOI : 10.1093/jac/dkt520
Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances, Nature Protocols, vol.217, issue.2, pp.163-75, 2008. ,
DOI : 10.1038/nprot.2007.521
Optimisation of colistin dosage in the treatment of multiresistant gram-negative infections, 2013. ,
Pharmacokinetic/Pharmacodynamic Investigation of Colistin against Pseudomonas aeruginosa Using an In Vitro Model, Antimicrobial Agents and Chemotherapy, vol.54, issue.9, pp.3783-3792, 2010. ,
DOI : 10.1128/AAC.00903-09
In Vitro Pharmacodynamic Properties of Colistin and Colistin Methanesulfonate against Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis, Antimicrobial Agents and Chemotherapy, vol.45, issue.3, pp.781-786, 2001. ,
DOI : 10.1128/AAC.45.3.781-785.2001
Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumannii, Antimicrobial Agents and Chemotherapy, vol.50, issue.9, pp.2946-50, 2006. ,
DOI : 10.1128/AAC.00103-06
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1563544
In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae, Journal of Antimicrobial Chemotherapy, vol.62, issue.6, pp.1311-1319, 2008. ,
DOI : 10.1093/jac/dkn425
Activity of Colistin against Heteroresistant Acinetobacter baumannii and Emergence of Resistance in an In Vitro Pharmacokinetic/Pharmacodynamic Model, Antimicrobial Agents and Chemotherapy, vol.51, issue.9, pp.3413-3418, 2007. ,
DOI : 10.1128/AAC.01571-06
Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model, Journal of Antimicrobial Chemotherapy, vol.61, issue.3, pp.636-678, 2008. ,
DOI : 10.1093/jac/dkm511
Attenuation of Colistin Bactericidal Activity by High Inoculum of Pseudomonas aeruginosa Characterized by a New Mechanism-Based Population Pharmacodynamic Model, Antimicrobial Agents and Chemotherapy, vol.54, issue.5, pp.2051-62, 2010. ,
DOI : 10.1128/AAC.00881-09
Colistin and Polymyxin B Dosage Regimens against Acinetobacter baumannii: Differences in Activity and the Emergence of Resistance, Antimicrobial Agents and Chemotherapy, vol.60, issue.7, pp.3921-3954, 2016. ,
DOI : 10.1128/AAC.02927-15
A pharmacokinetic/pharmacodynamic model developed for the effect of colistin on Clinical PK and PD of Colistin Author's personal copy Pseudomonas aeruginosa in vitro with evaluation of population pharmacokinetic variability on simulated bacterial killing ,
Efficacy of Tachyplesin III, Colistin, and Imipenem against a Multiresistant Pseudomonas aeruginosa Strain, Antimicrobial Agents and Chemotherapy, vol.51, issue.6, pp.2005-2015, 2007. ,
DOI : 10.1128/AAC.01576-06
In vitro activity of fosfomycin in combination with colistin against clinical isolates of carbapenem-resistant Pseudomas aeruginosa, The Journal of Antibiotics, vol.58, issue.9, pp.551-556, 2015. ,
DOI : 10.1038/ja.2015.27
In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates, Journal of Antimicrobial Chemotherapy, vol.69, issue.7, pp.1856-65, 2014. ,
DOI : 10.1093/jac/dku065
Potent Synergy and Sustained Bactericidal Activity of a Vancomycin-Colistin Combination versus Multidrug-Resistant Strains of Acinetobacter baumannii, Antimicrobial Agents and Chemotherapy, vol.54, issue.12, pp.5316-5338, 2010. ,
DOI : 10.1128/AAC.00922-10
In Vivo Efficacy of Glycopeptide-Colistin Combination Therapies in a Galleria mellonella Model of Acinetobacter baumannii Infection, Antimicrobial Agents and Chemotherapy, vol.55, issue.7, pp.3534-3541, 2011. ,
DOI : 10.1128/AAC.00230-11
In vitro activity of colistin in antimicrobial combination against carbapenem-resistant Acinetobacter baumannii isolated from patients with ventilator-associated pneumonia in Vietnam, Journal of Medical Microbiology, vol.64, issue.10, pp.1162-1171, 2015. ,
DOI : 10.1099/jmm.0.000137
Colistin and anti-Gram-positive bacterial agents against Acinetobacter baumannii, Revista da Sociedade Brasileira de Medicina Tropical, vol.47, issue.4, pp.451-457, 2014. ,
DOI : 10.1590/0037-8682-0081-2014
URL : http://doi.org/10.1590/0037-8682-0081-2014
: profiling the time course of synergistic killing and prevention of resistance, Journal of Antimicrobial Chemotherapy, vol.70, issue.5, pp.1434-1476, 2015. ,
DOI : 10.1093/jac/dku567
A prospective evaluation of synergistic effect of sulbactam and tazobactam combination with meropenem or colistin against multidrug resistant Acinetobacter baumannii ,
In vitro activity of polymyxins in combination with ??-lactams against clinical strains of Pseudomonas aeruginosa, International Journal of Antimicrobial Agents, vol.38, issue.5 ,
DOI : 10.1016/j.ijantimicag.2011.06.012
In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii, The Journal of Antibiotics, vol.22, issue.12, pp.705-713, 2013. ,
DOI : 10.1128/AAC.32.1.42
Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU, Diagnostic Microbiology and Infectious Disease, vol.70, issue.3, pp.380-386, 2011. ,
DOI : 10.1016/j.diagmicrobio.2011.03.003
Evaluation of Double- and Triple-Antibiotic Combinations for VIM- and NDM-Producing Klebsiella pneumoniae by In Vitro Time-Kill Experiments, Antimicrobial Agents and Chemotherapy, vol.58, issue.3, pp.1757-62, 2014. ,
DOI : 10.1128/AAC.00741-13
In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii, Journal of Antimicrobial Chemotherapy, vol.66, issue.5, pp.1047-51, 2011. ,
DOI : 10.1093/jac/dkr069
model, Infectious Diseases, vol.48, issue.3, pp.189-94, 2016. ,
DOI : 10.1128/AAC.02501-12
URL : https://hal.archives-ouvertes.fr/hal-01091232
Antimicrobial Combinations against Pan-Resistant Acinetobacter baumannii Isolates with Different Resistance Mechanisms, PLOS ONE, vol.59, issue.3, p.151270, 2016. ,
DOI : 10.1371/journal.pone.0151270.s001
URL : http://doi.org/10.1371/journal.pone.0151270
In Vitro Responses of Acinetobacter baumannii to Two- and Three-Drug Combinations following Exposure to Colistin and Doripenem, Antimicrobial Agents and Chemotherapy, vol.58, issue.2, pp.1195-1204, 2014. ,
DOI : 10.1128/AAC.01779-13
In Vitro Synergy of Colistin Combinations against Colistin-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae Isolates, Antimicrobial Agents and Chemotherapy, vol.56, issue.9, pp.4856-61, 2012. ,
DOI : 10.1128/AAC.05996-11
as quantified in a PK/PD model, Journal of Antimicrobial Chemotherapy, vol.71, issue.5, pp.1279-90, 2016. ,
DOI : 10.1093/jac/dkv488
Elucidation of the Pharmacokinetic/Pharmacodynamic Determinant of Colistin Activity against Pseudomonas aeruginosa in Murine Thigh and Lung Infection Models, Antimicrobial Agents and Chemotherapy, vol.54, issue.3, pp.1117-1141, 2010. ,
DOI : 10.1128/AAC.01114-09
fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models, Journal of Antimicrobial Chemotherapy, vol.65, issue.9, pp.1984-90, 2010. ,
DOI : 10.1093/jac/dkq226
New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection, J Antimicrob Chemother, vol.70, pp.3291-3298, 2015. ,
Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model, PLOS ONE, vol.40, issue.6, p.157757, 2016. ,
DOI : 10.1371/journal.pone.0157757.s001
Activity of Tigecycline in Combination with Colistin, Meropenem, Rifampin, or Gentamicin against KPC-Producing Enterobacteriaceae in a Murine Thigh Infection Model, Antimicrobial Agents and Chemotherapy, vol.57, issue.12, pp.6028-6061, 2013. ,
DOI : 10.1128/AAC.00891-13
sepsis in corticosteroid receipt mice: tigecycline or colistin monotherapy versus tigecycline/colistin combination, Journal of Chemotherapy, vol.16, issue.5, pp.276-81, 2014. ,
DOI : 10.1111/1469-0691.12091
Synergistic combinations of polymyxins, International Journal of Antimicrobial Agents, vol.48, issue.6, pp.607-620, 2016. ,
DOI : 10.1016/j.ijantimicag.2016.09.014
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237374
In vitro activities of rifampin, colistin, sulbactam and tigecycline tested alone and in combination against extensively drug-resistant Acinetobacter baumannii, The Journal of Antibiotics, vol.38, issue.9, pp.677-80, 2014. ,
DOI : 10.3349/ymj.2012.53.5.974